Investment in Reakiro


As ongoing research suggests, CBD has a positive impact on a range of health issues, such as anxiety, depression, sleeplessness, cancer related symptom alleviation, as well as general pain relieve properties. Mission Gate primarily invested in Reakiro to boost its production capabilities and get EU GMP certification.

Reakiro Europe operates modern processing facilities for the refining and packaging of products derived from their own specially selected and grown CBD hemp varieties. It supplies CBD oils, sprays, capsules, tinctures, hand sanitizers and other products mainly to the UK and other European markets. As CBD legislation spreads throughout the world, Reakiro’s ambition is to become the number 1 CBD company globally.